keyword
https://read.qxmd.com/read/38652457/genome-scale-model-of-rothia-mucilaginosa-predicts-gene-essentialities-and-reveals-metabolic-capabilities
#1
JOURNAL ARTICLE
Nantia Leonidou, Lisa Ostyn, Tom Coenye, Aurélie Crabbé, Andreas Dräger
Cystic fibrosis (CF), an inherited genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator gene, results in sticky and thick mucosal fluids. This environment facilitates the colonization of various microorganisms, some of which can cause acute and chronic lung infections, while others may positively impact the disease. Rothia mucilaginosa , an oral commensal, is relatively abundant in the lungs of CF patients. Recent studies have unveiled its anti-inflammatory properties using in vitro three-dimensional lung epithelial cell cultures and in vivo mouse models relevant to chronic lung diseases...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38643839/fusobacterium-nucleatum-carcinogenesis-and-drug-delivery-interventions
#2
REVIEW
Zhenzhen Chen, Leaf Huang
The microbiome has emerged as a significant biomarker and modulator in cancer development and treatment response. Recent research highlights the notable role of Fusobacterium nucleatum (F. nucleatum) in various tumor types, including breast, colorectal, esophageal, gastric, pancreatic, and lung cancers. Accumulating evidence suggests that the local microbial community forms an integral component of the tumor microenvironment, with bacterial communities within tumors displaying specificity to tumor types. Mechanistic investigations indicate that tumor-associated microbiota can directly influence tumor initiation, progression, and responses to chemotherapy or immunotherapy...
April 19, 2024: Advanced Drug Delivery Reviews
https://read.qxmd.com/read/38643126/bacterial-interactome-disturbance-in-chronic-obstructive-pulmonary-disease-clinical-stability-and-exacerbations
#3
JOURNAL ARTICLE
Wei Xiao, Yi-Long Chen, Long-Yi Du, Jiqiu Wu, Zhang Wang, Bing Mao, Fu-Qiang Wen, Peter Gerard Gibson, Vanessa M McDonald, Haopeng Yu, Juan-Juan Fu
RATIONALE: Our understanding of airway dysbiosis in chronic obstructive pulmonary disease (COPD) remains incomplete, which may be improved by unraveling the complexity in microbial interactome. OBJECTIVES: To characterize reproducible features of airway bacterial interactome in COPD at clinical stability and during exacerbation, and evaluate their associations with disease phenotypes. METHODS: We performed weighted ensemble-based co-occurrence network analysis of 1742 sputum microbiomes from published and new microbiome datasets, comprising two case-control studies of stable COPD versus healthy control, two studies of COPD stability versus exacerbation, and one study with exacerbation-recovery time series data...
April 20, 2024: Respiratory Research
https://read.qxmd.com/read/38643115/saliva%C3%A2-microbiome%C3%A2-derived-signatures-expected-to-become-a-potential-biomarker-for-pulmonary-nodules-mcepn-1
#4
JOURNAL ARTICLE
Yifeng Ren, Qiong Ma, Xiao Zeng, Chunxia Huang, Shiyan Tan, Xi Fu, Chuan Zheng, Fengming You, Xueke Li
BACKGROUND: Oral microbiota imbalance is associated with the progression of various lung diseases, including lung cancer. Pulmonary nodules (PNs) are often considered a critical stage for the early detection of lung cancer; however, the relationship between oral microbiota and PNs remains unknown. METHODS: We conducted a 'Microbiome with pulmonary nodule series study 1' (MCEPN-1) where we compared PN patients and healthy controls (HCs), aiming to identify differences in oral microbiota characteristics and discover potential microbiota biomarkers for non-invasive, radiation-free PNs diagnosis and warning in the future...
April 20, 2024: BMC Microbiology
https://read.qxmd.com/read/38641145/revolutionising-lung-health-exploring-the-latest-breakthroughs-and-future-prospects-of-synbiotic-nanostructures-in-lung-diseases
#5
REVIEW
Ayeh Bani Saeid, Gabriele De Rubis, Kylie A Williams, Stewart Yeung, Dinesh Kumar Chellappan, Sachin Kumar Singh, Gaurav Gupta, Philip M Hansbro, Mohammad-Ali Shahbazi, Monica Gulati, Indu Pal Kaur, Hélder A Santos, Keshav Raj Paudel, Kamal Dua
The escalating prevalence of lung diseases underscores the need for innovative therapies. Dysbiosis in human body microbiome has emerged as a significant factor in these diseases, indicating a potential role for synbiotics in restoring microbial equilibrium. However, effective delivery of synbiotics to the target site remains challenging. Here, we aim to explore suitable nanoparticles for encapsulating synbiotics tailored for applications in lung diseases. Nanoencapsulation has emerged as a prominent strategy to address the delivery challenges of synbiotics in this context...
April 17, 2024: Chemico-biological Interactions
https://read.qxmd.com/read/38640403/gonadal-sex-and-chromosome-complement-influence-the-gut-microbiome-in-a-mouse-model-of-allergic-airway-inflammation
#6
JOURNAL ARTICLE
Carolyn Damilola Ekpruke, Rachel Alford, Erik Parker, Patricia Silveyra
Evidence abounds that gut microbiome components are associated with sex disparities in the immune system. However, it remains unclear whether the observed sex disparity in asthma incidence is associated with sex-dependent differences in immune-modulating gut microbiota, and/or its influence on allergic airway inflammatory processes. Using a mouse model of house dust mite (HDM)-induced allergic inflammation and the four core genotypes (FCG) model, we have previously reported sex differences in lung inflammatory phenotypes...
April 19, 2024: Physiological Genomics
https://read.qxmd.com/read/38635003/application-of-microbiome-based-therapies-in-chronic-respiratory-diseases
#7
REVIEW
Se Hee Lee, Jang Ho Lee, Sei Won Lee
The application of microbiome-based therapies in various areas of human disease has recently increased. In chronic respiratory disease, microbiome-based clinical applications are considered compelling options due to the limitations of current treatments. The lung microbiome is ecologically dynamic and affected by various conditions, and dysbiosis is associated with disease severity, exacerbation, and phenotype as well as with chronic respiratory disease endotype. However, it is not easy to directly modulate the lung microbiome...
April 18, 2024: Journal of Microbiology / the Microbiological Society of Korea
https://read.qxmd.com/read/38633306/microbiome-features-in-bronchoalveolar-lavage-fluid-of-patients-with-idiopathic-inflammatory-myopathy-related-interstitial-lung-disease
#8
JOURNAL ARTICLE
Liyan Zhang, Xueqing Liu, Bijun Fan, Jiajun Chen, Jie Chen, Qiuhong Li, Xueling Wu
BACKGROUND: Interstitial lung disease (ILD) is a common complication of idiopathic inflammatory myopathy (IIM), which is one of the connective tissue diseases (CTD). It can lead to poor prognosis and increased mortality. However, the distribution and role of the lower respiratory tract (LRT) microbiome in patients with IIM-ILD remains unclear. This study aimed to investigate the microbial diversity and community differences in bronchoalveolar lavage fluid (BALF) in patients with IIM-ILD...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38632423/exploring-the-lung-microbiome-s-role-in-disease
#9
Anthony King
No abstract text is available yet for this article.
April 17, 2024: Nature
https://read.qxmd.com/read/38626906/the-oral-lung-microbiome-axis-in-connective-tissue-disease-related-interstitial-lung-disease
#10
JOURNAL ARTICLE
Kale S Bongers, Angeline Massett, David N O'Dwyer
Connective tissue disease-related interstitial lung disease (CTD-ILD) is a frequent and serious complication of CTD, leading to high morbidity and mortality. Unfortunately, its pathogenesis remains poorly understood; however, one intriguing contributing factor may be the microbiome of the mouth and lungs. The oral microbiome, which is a major source of the lung microbiome through recurrent microaspiration, is altered in ILD patients. Moreover, in recent years, several lines of evidence suggest that changes in the oral and lung microbiota modulate the pulmonary immune response and thus may play a role in the pathogenesis of ILDs, including CTD-ILD...
April 16, 2024: Seminars in Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38622728/exploring-the-immune-inflammatory-mechanism-of-maxing-shigan-decoction-in-treating-influenza-virus-a-induced-pneumonia-based-on-an-integrated-strategy-of-single-cell-transcriptomics-and-systems-biology
#11
JOURNAL ARTICLE
Shiying Zhang, Bei Li, Liuting Zeng, Kailin Yang, Junyao Jiang, Fangguo Lu, Ling Li, Weiqing Li
BACKGROUND: Influenza is an acute respiratory infection caused by influenza virus. Maxing Shigan Decoction (MXSGD) is a commonly used traditional Chinese medicine prescription for the prevention and treatment of influenza. However, its mechanism remains unclear. METHOD: The mice model of influenza A virus pneumonia was established by nasal inoculation. After 3 days of intervention, the lung index was calculated, and the pathological changes of lung tissue were detected by HE staining...
April 15, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38617000/a-chronic-stress-induced-microbiome-perturbation-highly-enriched-in-ruminococcaceae_ucg-014-promotes-colorectal-cancer-growth-and-metastasis
#12
JOURNAL ARTICLE
Ling Zhao, Xinxin Hou, Yuanyuan Feng, Yingru Zhang, Shiyun Shao, Xinnan Wu, Junfeng Jim Zhang, Zhaozhou Zhang
Purpose: Mounting evidence indicates that psychological stress adversely affects cancer progression including tumor growth and metastasis. The aim of this study was to investigate the role of chronic stress-induced microbiome perturbation in colorectal cancer (CRC) progression. Methods: Chronic restraint stress (CRS) was used to establish the chronic stress mouse model, behavioral tests were used for the CRS model evaluation. Subcutaneous xenograft model and lung metastasis model were established to investigate the growth and metastasis of CRC promoted by CRS exposure...
2024: International Journal of Medical Sciences
https://read.qxmd.com/read/38612871/gut-microbiome-and-transcriptomic-changes-in-cigarette-smoke-exposed-mice-compared-to-copd-and-cd-patient-datasets
#13
JOURNAL ARTICLE
Lei Wang, Pim J Koelink, Johan Garssen, Gert Folkerts, Paul A J Henricks, Saskia Braber
Chronic obstructive pulmonary disease (COPD) patients and smokers have a higher incidence of intestinal disorders. The aim of this study was to gain insight into the transcriptomic changes in the lungs and intestines, and the fecal microbial composition after cigarette smoke exposure. Mice were exposed to cigarette smoke and their lung and ileum tissues were analyzed by RNA sequencing. The top 15 differentially expressed genes were investigated in publicly available gene expression datasets of COPD and Crohn's disease (CD) patients...
April 5, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612860/microbiota-and-immunity-during-respiratory-infections-lung-and-gut-affair
#14
REVIEW
Veronica Marrella, Federico Nicchiotti, Barbara Cassani
Bacterial and viral respiratory tract infections are the most common infectious diseases, leading to worldwide morbidity and mortality. In the past 10 years, the importance of lung microbiota emerged in the context of pulmonary diseases, although the mechanisms by which it impacts the intestinal environment have not yet been fully identified. On the contrary, gut microbial dysbiosis is associated with disease etiology or/and development in the lung. In this review, we present an overview of the lung microbiome modifications occurring during respiratory infections, namely, reduced community diversity and increased microbial burden, and of the downstream consequences on host-pathogen interaction, inflammatory signals, and cytokines production, in turn affecting the disease progression and outcome...
April 5, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612702/insights-into-the-adolescent-cystic-fibrosis-airway-microbiome-using-shotgun-metagenomics
#15
JOURNAL ARTICLE
Gillian McDermott, Aaron Walsh, Fiona Crispie, Susanna Frost, Peter Greally, Paul D Cotter, Orla O'Sullivan, Julie Renwick
Cystic fibrosis (CF) is an inherited genetic disorder which manifests primarily in airway disease. Recent advances in molecular technologies have unearthed the diverse polymicrobial nature of the CF airway. Numerous studies have characterised the genus-level composition of this airway community using targeted 16S rDNA sequencing. Here, we employed whole-genome shotgun metagenomics to provide a more comprehensive understanding of the early CF airway microbiome. We collected 48 sputum samples from 11 adolescents and children with CF over a 12-month period and performed shotgun metagenomics on the Illumina NextSeq platform...
March 31, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38599211/a-pan-cancer-analysis-of-the-microbiome-in-metastatic-cancer
#16
JOURNAL ARTICLE
Thomas W Battaglia, Iris L Mimpen, Joleen J H Traets, Arne van Hoeck, Laurien J Zeverijn, Birgit S Geurts, Gijs F de Wit, Michaël Noë, Ingrid Hofland, Joris L Vos, Sten Cornelissen, Maartje Alkemade, Annegien Broeks, Charlotte L Zuur, Edwin Cuppen, Lodewyk Wessels, Joris van de Haar, Emile Voest
Microbial communities are resident to multiple niches of the human body and are important modulators of the host immune system and responses to anticancer therapies. Recent studies have shown that complex microbial communities are present within primary tumors. To investigate the presence and relevance of the microbiome in metastases, we integrated mapping and assembly-based metagenomics, genomics, transcriptomics, and clinical data of 4,160 metastatic tumor biopsies. We identified organ-specific tropisms of microbes, enrichments of anaerobic bacteria in hypoxic tumors, associations between microbial diversity and tumor-infiltrating neutrophils, and the association of Fusobacterium with resistance to immune checkpoint blockade (ICB) in lung cancer...
April 5, 2024: Cell
https://read.qxmd.com/read/38590519/-faecalibacterium-duncaniae-as-a-novel-next-generation-probiotic-against-influenza
#17
JOURNAL ARTICLE
Loïc Chollet, Séverine Heumel, Lucie Deruyter, Fabrice Bouilloux, Lou Delval, Véronique Robert, Marie-Hélène Gevaert, Muriel Pichavant, Valentin Sencio, Cyril Robil, Isabelle Wolowczuk, Harry Sokol, Sandrine Auger, Alexandre Douablin, Philippe Langella, Jean-Marc Chatel, Corinne Grangette, François Trottein
The gut-lung axis is critical during viral respiratory infections such as influenza. Gut dysbiosis during infection translates into a massive drop of microbially produced short-chain fatty acids (SCFAs). Among them, butyrate is important during influenza suggesting that microbiome-based therapeutics targeting butyrate might hold promises. The butyrate-producing bacterium Faecalibacterium duncaniae (formerly referred to as F. prausnitzii ) is an emerging probiotic with several health-promoting characteristics...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38589392/dermal-injury-drives-a-skin-to-gut-axis-that-disrupts-the-intestinal-microbiome-and-intestinal-immune-homeostasis-in-mice
#18
JOURNAL ARTICLE
Tatsuya Dokoshi, Yang Chen, Kellen J Cavagnero, Gibraan Rahman, Daniel Hakim, Samantha Brinton, Hana Schwarz, Elizabeth A Brown, Alan O'Neill, Yoshiyuki Nakamura, Fengwu Li, Nita H Salzman, Rob Knight, Richard L Gallo
The composition of the microbial community in the intestine may influence the functions of distant organs such as the brain, lung, and skin. These microbes can promote disease or have beneficial functions, leading to the hypothesis that microbes in the gut explain the co-occurrence of intestinal and skin diseases. Here, we show that the reverse can occur, and that skin directly alters the gut microbiome. Disruption of the dermis by skin wounding or the digestion of dermal hyaluronan results in increased expression in the colon of the host defense genes Reg3 and Muc2, and skin wounding changes the composition and behavior of intestinal bacteria...
April 8, 2024: Nature Communications
https://read.qxmd.com/read/38585702/causal-associations-of-genetically-predicted-gut-microbiota-and-blood-metabolites-with-inflammatory-states-and-risk-of-infections-a-mendelian-randomization-analysis
#19
JOURNAL ARTICLE
Yingjian Liu, Qian Zhu, Gongjie Guo, Zhipeng Xie, Senlin Li, Chengyang Lai, Yonglin Wu, Liansheng Wang, Shilong Zhong
BACKGROUND: Inflammation serves as a key pathologic mediator in the progression of infections and various diseases, involving significant alterations in the gut microbiome and metabolism. This study aims to probe into the potential causal relationships between gut microbial taxa and human blood metabolites with various serum inflammatory markers (CRP, SAA1, IL-6, TNF-α, WBC, and GlycA) and the risks of seven common infections (gastrointestinal infections, dysentery, pneumonia, bacterial pneumonia, bronchopneumonia and lung abscess, pneumococcal pneumonia, and urinary tract infections)...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38585101/short-chain-fatty-acid-scfa-as-a-connecting-link-between-microbiota-and-gut-lung-axis-a-potential-therapeutic-intervention-to-improve-lung-health
#20
REVIEW
Anjali Verma, Tannu Bhagchandani, Ankita Rai, Nikita, Urvinder Kaur Sardarni, Neel Sarovar Bhavesh, Sameer Gulati, Rupali Malik, Ravi Tandon
The microbiome is an integral part of the human gut, and it plays a crucial role in the development of the immune system and homeostasis. Apart from the gut microbiome, the airway microbial community also forms a distinct and crucial part of the human microbiota. Furthermore, several studies indicate the existence of communication between the gut microbiome and their metabolites with the lung airways, called "gut-lung axis". Perturbations in gut microbiota composition, termed dysbiosis, can have acute and chronic effects on the pathophysiology of lung diseases...
April 2, 2024: ACS Omega
keyword
keyword
72553
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.